Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Gils

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
The Journal of Pediatrics|September 5, 2021
Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination TherapyKaren van Hoeve, Nasim Sadat Seyed Tabib, Erwin Dreesen, et al.
Journal of Bacteriology|January 4, 2003
Characterization of a novel intracellular endopeptidase of the alpha/beta hydrolase family from Streptomyces coelicolor A3(2)István Nagy, Tisha Banerjee, Tomohiro Tamura, et al.
Inflammatory Bowel Diseases|August 11, 2019
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral CenterMichiel Bronswijk, Annick Moens, Matthias Lenfant, et al.
Analytical Chemistry|March 4, 2014
Probing the force-induced dissociation of aptamer-protein complexesElena Pérez-Ruiz, Marijn Kemper, Dragana Spasic, et al.
Thrombosis and Haemostasis|June 23, 2017
Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potentialChengliang Wu, Alan R Stafford, James C Fredenburgh, et al.
Clinical and Translational Gastroenterology|December 9, 2016
Rapid Test for Infliximab Drug Concentration Allows Immediate Dose AdaptationThomas Van Stappen, Lize Bollen, Niels Vande Casteele, et al.
Analytical Chemistry|February 23, 2017
Immunoassay for Detection of Infliximab in Whole Blood Using a Fiber-Optic Surface Plasmon Resonance BiosensorJiadi Lu, Dragana Spasic, Filip Delport, et al.
Inflammatory Bowel Diseases|October 25, 2019
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral CenterMichiel Bronswijk, Annick Moens, Matthias Lenfant, et al.
Inflammatory Bowel Diseases|November 16, 2017
Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over TimeSumin Bian, Erwin Dreesen, Ho Tsun Tang, et al.
The AAPS Journal|December 20, 2018
Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic InformationIris Detrez, Ganel Schops, Jolien Lefrère, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
The Journal of Pediatrics|September 5, 2021
Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination TherapyKaren van Hoeve, Nasim Sadat Seyed Tabib, Erwin Dreesen, et al.
Journal of Bacteriology|January 4, 2003
Characterization of a novel intracellular endopeptidase of the alpha/beta hydrolase family from Streptomyces coelicolor A3(2)István Nagy, Tisha Banerjee, Tomohiro Tamura, et al.
Inflammatory Bowel Diseases|August 11, 2019
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral CenterMichiel Bronswijk, Annick Moens, Matthias Lenfant, et al.
Analytical Chemistry|March 4, 2014
Probing the force-induced dissociation of aptamer-protein complexesElena Pérez-Ruiz, Marijn Kemper, Dragana Spasic, et al.
Thrombosis and Haemostasis|June 23, 2017
Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potentialChengliang Wu, Alan R Stafford, James C Fredenburgh, et al.
Clinical and Translational Gastroenterology|December 9, 2016
Rapid Test for Infliximab Drug Concentration Allows Immediate Dose AdaptationThomas Van Stappen, Lize Bollen, Niels Vande Casteele, et al.
Analytical Chemistry|February 23, 2017
Immunoassay for Detection of Infliximab in Whole Blood Using a Fiber-Optic Surface Plasmon Resonance BiosensorJiadi Lu, Dragana Spasic, Filip Delport, et al.
Inflammatory Bowel Diseases|October 25, 2019
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral CenterMichiel Bronswijk, Annick Moens, Matthias Lenfant, et al.
Inflammatory Bowel Diseases|November 16, 2017
Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over TimeSumin Bian, Erwin Dreesen, Ho Tsun Tang, et al.
The AAPS Journal|December 20, 2018
Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic InformationIris Detrez, Ganel Schops, Jolien Lefrère, et al.
Pageof 17